Edgar Pérez‐Herrero

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H -receptor antagonists

C Albet, José A. G. Agúndez, Edgar Pérez‐Herrero et al. · Clinical Pharmacology & Therapeutics · 1999 · 130 citations

Chitosan–Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM‐1‐Targeting Nanocarriers, Enabling GI Targeting In Vivo

Rasa Ghaffarian, Edgar Pérez‐Herrero, Hyun‐Taek Oh et al. · Advanced Functional Materials · 2016 · 120 citations

Nanoparticles, Intestinal Release, Gastric Ph +19

Development of a new technology for the production of microcapsules based in atomization processes

Edgar Pérez‐Herrero, Eva M. Martín del Valle, Miguel Á. Galán · Chemical Engineering Journal · 2006 · 74 citations

Materials Science, Experimental Synthesis, Chemical Engineering +8

Bone regeneration in osteoporosis by delivery BMP-2 and PRGF from tetronic–alginate composite thermogel

Elisabet Segredo-Morales, Patricia García‐García, Ricardo Reyes et al. · International Journal of Pharmaceutics · 2018 · 56 citations

Regenerative Medicine, Tissue Engineering, Synthetic Bone Substitute +11

Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance

Joshua Kim, Sauradeep Sinha, Melani Solomon et al. · Biomaterials · 2017 · 38 citations · Full text

Nanoparticles, Nanomedicine, Receptor-targeted Drug Nanocarriers +8